Standout Papers

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy 2023 2026 202482
  1. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy (2023)
    Mohit Mathur, Jonathan Barratt et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells
2025 Standout
Perioperative Care in Cardiac Surgery: A Joint Consensus Statement by the Enhanced Recovery After Surgery (ERAS) Cardiac Society, ERAS International Society, and The Society of Thoracic Surgeons (STS)
2024 Standout
2 intermediate papers

Works of Jill Yarbrough being referenced

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
2023 Standout
A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
1993

Author Peers

Author Last Decade Papers Cites
Jill Yarbrough 43 112 94 105 13 322
Núria Serra 17 54 88 39 18 347
Nobuyuki Umegae 45 17 101 36 9 308
Jessica Connor 20 88 21 24 12 273
Kouichi Utsumi 19 24 154 27 19 326
Melanie Eschborn 5 72 39 44 11 353
Geneviève Beaurain 22 41 36 27 9 345
Hee Young Kim 19 69 30 30 17 345
W.H. Chase 19 19 80 62 13 359
Samuel Hurwitz 16 90 29 22 16 283
Norman S. Olsen 20 31 37 18 13 369

All Works

Loading papers...

Rankless by CCL
2026